Cryptococcosis is an opportunistic infection caused by the encapsulated yeast Cryptococcus neoformans. This ubiquitous organism has emerged as a frequent finding in immunosuppressed patients, especially those with underlying malignancies, organ transplants, and the acquired immune deficiency syndrome (AIDS). Cutaneous manifestations of cryptococcosis occur in 10 to 15% of patients having systemic involvement. These skin lesions may simulate a variety of different disease entities.
Methods:
A case of crytococcosis mimicking a basal cell carcinoma is the subject of a case report presentation.
Results:
A case of cutaneous cryptococcosis mimicking basal cell carcinoma occurred in a patient with AIDS, who did not appear to have dissemination, but was treated aggressively to stem possible occult systemic disease.
Conclusion:
Cutaneous crytococcosis may mimic other dermatologic disorders.
Kwong-ChungKJBennettJE. Medical mycology. Philadelphia: Lea and Febiger, 1992:397–446.
3.
EllisDHPfeifferTJ. Natural habitat of Cryptococcus neoformans var. gattii. J Clin Microbiol1990; 28:1642–1644.
4.
YantosVACarneyJGreerDL. Review of the morphological variations in cutaneous cryptococcosis with a new case resembling varicella. Cutis1994; 54:343–347.
RicoMJPenneysNS. Cutaneous cryptococcosis resembling molluscum contagiosum in a patient with AIDS. Arch Dermatol1985; 121:901–902.
11.
RicchiEScaraniPChiodoF. Cutaneous cryptococcosis and AIDS. J Am Acad Dermatol1991; 25:335–337.
12.
DurdenFMElewskiB. Cutaneous involvement with Cryptococcus neoformans in AIDS. Arch Dermatol1994; 30:844–848.
13.
ManriquePMayoJAlvarezJA. Polymorphous cutaneous cryptococcosis: Nodular, herpes-like, and molluscum-like lesions in a patient with the acquired immunodeficiency syndrome. J Am Acad Dermatol1992; 26:122–124.
14.
Dimino-EmmeLGurevitchAW. Cutaneous manifestations of disseminated cryptococcus. J Am Acad Dermatol1995; 32: 844–850.
FeldmanSRFleischerABResnickSD. Fluconazole treatment of cutaneous cryptococcosis without evidence of systemic disease. J Am Acad Dermatol1984; 11:371–374.
17.
GlaserJBGardenA. Inoculation of cryptococcosis without transmission of the aquired immunodeficiency syndrome. N Engl J Med1985; 313:266.
18.
SussmanEJMcMahonFWrightDFriedmanHM. Cutaneous cryptococcosis without evidence of systemic involvement. J Am Acad Dermatol1984; 11:371–374.
19.
GranierFKanitakisJHermierC. Localized cutaneous cryptococcosis successfully treated with ketoconozole. J Am Acad Dermatol1987; 16:243–249.
20.
GohCL. Cutaneous cryptococcosis successfully treated with itraconazole. Cutis1993; 51:377–380.
MurakawaGJKerschmannRBergerT. Cutaneous cryptococcus infection and AIDS. Arch Dermatol1996; 132:545–548.
23.
SaagMSPowderlyWGCloudGA. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. N Engl J Med1992; 326: 83–89.
24.
ChuckSLSandeMA. Infections with Cryptocccus neoformans in the acquired immunodeficiency syndrome. N Engl J Med1989; 321:794–799.
25.
VivianiMA. Opportunistic fungal infections in patients with acquired immune deficiency syndrome. Chemotherapy1992; 38:35–42.
PowderlyWGSaagMSCloudGA. A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patient with the acquired immunodeficiency syndrome. N Engl J Med1992; 326:793–798.
